Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Humacyte Inc (NASDAQ: HUMA) was $4.12 for the day, down -6.15% from the previous closing price of $4.39. In other words, the price has decreased by -$6.15 from its previous closing price. On the day, 2.77 million shares were traded. HUMA stock price reached its highest trading level at $4.48 during the session, while it also had its lowest trading level at $4.04.
Ratios:
Our analysis of HUMA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.10 and its Current Ratio is at 1.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 20, 2024, Reiterated its Buy rating but revised its target price to $15 from $12 previously.
On December 11, 2023, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $6.
Piper Sandler Upgraded its Underweight to Neutral on August 14, 2023, whereas the target price for the stock was revised from $2.75 to $3.50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 04 ’24 when Constantino Michael T. bought 4,600 shares for $4.39 per share. The transaction valued at 20,181 led to the insider holds 16,950 shares of the business.
Niklason Laura E bought 1,797 shares of HUMA for $7,979 on Nov 19 ’24. The President, CEO and Director now owns 243,851 shares after completing the transaction at $4.44 per share. On Nov 19 ’24, another insider, Dougan Brady W, who serves as the Director of the company, bought 1,797 shares for $4.44 each. As a result, the insider paid 7,979 and bolstered with 243,851 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUMA now has a Market Capitalization of 530112160 and an Enterprise Value of 515488128.
Stock Price History:
The Beta on a monthly basis for HUMA is 1.34, which has changed by 0.70155036 over the last 52 weeks, in comparison to a change of 0.23147523 over the same period for the S&P500. Over the past 52 weeks, HUMA has reached a high of $9.97, while it has fallen to a 52-week low of $2.48. The 50-Day Moving Average of the stock is -11.92%, while the 200-Day Moving Average is calculated to be -25.59%.
Shares Statistics:
HUMA traded an average of 4.83M shares per day over the past three months and 4450890 shares per day over the past ten days. A total of 119.84M shares are outstanding, with a floating share count of 104.37M. Insiders hold about 18.88% of the company’s shares, while institutions hold 27.93% stake in the company. Shares short for HUMA as of 1735603200 were 29620351 with a Short Ratio of 6.13, compared to 1732838400 on 20333918. Therefore, it implies a Short% of Shares Outstanding of 29620351 and a Short% of Float of 29.659997999999998.
